Co-Diagnostics, Inc.
CODX
$0.35
-$0.01-2.78%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 770.00K | 675.90K | 605.50K | 642.20K | 991.50K |
| Total Other Revenue | 3.15M | 6.65M | 8.53M | 6.04M | 5.82M |
| Total Revenue | 3.92M | 7.32M | 9.14M | 6.68M | 6.81M |
| Cost of Revenue | 999.10K | 3.71M | 3.67M | 3.92M | 4.18M |
| Gross Profit | 2.92M | 3.61M | 5.47M | 2.76M | 2.63M |
| SG&A Expenses | 20.64M | 19.92M | 19.63M | 20.90M | 21.14M |
| Depreciation & Amortization | 1.38M | 1.33M | 1.28M | 1.25M | 1.23M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.00M | 47.32M | 47.84M | 49.69M | 49.52M |
| Operating Income | -40.08M | -40.00M | -38.70M | -43.02M | -42.71M |
| Income Before Tax | -37.58M | -37.38M | -35.81M | -39.38M | -38.11M |
| Income Tax Expenses | 57.40K | 3.90M | 1.76M | -495.10K | -2.78M |
| Earnings from Continuing Operations | -37.64 | -41.28 | -37.57 | -38.89 | -35.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -37.64M | -41.28M | -37.57M | -38.89M | -35.33M |
| EBIT | -40.08M | -40.00M | -38.70M | -43.02M | -42.71M |
| EBITDA | -38.70M | -38.67M | -37.42M | -41.77M | -41.48M |
| EPS Basic | -1.24 | -1.38 | -1.27 | -1.32 | -1.20 |
| Normalized Basic EPS | -0.81 | -0.81 | -0.79 | -0.89 | -0.88 |
| EPS Diluted | -1.24 | -1.38 | -1.27 | -1.32 | -1.21 |
| Normalized Diluted EPS | -0.81 | -0.81 | -0.79 | -0.89 | -0.88 |
| Average Basic Shares Outstanding | 121.34M | 119.93M | 118.80M | 117.76M | 117.40M |
| Average Diluted Shares Outstanding | 121.34M | 119.93M | 118.80M | 117.76M | 117.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |